MXPA03007332A - Levothyroxine compositions and methods. - Google Patents
Levothyroxine compositions and methods.Info
- Publication number
- MXPA03007332A MXPA03007332A MXPA03007332A MXPA03007332A MXPA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- sodium
- making
- levothyroxine
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26900901P | 2001-02-15 | 2001-02-15 | |
US26899801P | 2001-02-15 | 2001-02-15 | |
PCT/US2002/004665 WO2003070217A1 (en) | 2002-02-15 | 2002-02-15 | Levothyroxine compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03007332A true MXPA03007332A (en) | 2005-11-10 |
Family
ID=28044645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03007332A MXPA03007332A (en) | 2001-02-15 | 2002-02-15 | Levothyroxine compositions and methods. |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2002240394A1 (en) |
BR (1) | BR0207299A (en) |
MX (1) | MXPA03007332A (en) |
NO (1) | NO20033636L (en) |
-
2002
- 2002-02-15 BR BR0207299-8A patent/BR0207299A/en not_active IP Right Cessation
- 2002-02-15 MX MXPA03007332A patent/MXPA03007332A/en unknown
- 2002-02-15 AU AU2002240394A patent/AU2002240394A1/en not_active Abandoned
-
2003
- 2003-08-15 NO NO20033636A patent/NO20033636L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0207299A (en) | 2005-02-09 |
AU2002240394A1 (en) | 2003-09-09 |
NO20033636L (en) | 2003-10-15 |
NO20033636D0 (en) | 2003-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1096034A1 (en) | A solid dosage form comprising a fibrate | |
BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
PT1412384E (en) | Stable formulation of modified glp-1 | |
BR0003158A (en) | Instant melting oral dosage formulation | |
TNSN01130A1 (en) | EXTENDED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGUES | |
MY151468A (en) | Controlled release solid preparation | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
IL153297A0 (en) | Compounds and compositions for delivering active agents | |
PT893992E (en) | FORMS OF FAST DISINTEGRATION ORAL DOSAGE | |
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
HK1080364A1 (en) | Oral pharmaceutical forms of liquid drugs having improved bioavailability | |
MX2009003030A (en) | Galenic form for the trans-mucosal delivery of active ingredients. | |
AU2002231654A1 (en) | Pharmaceutical paste comprising an acid-labile active ingredient | |
ES2110212T3 (en) | EFFERVESCENT PHARMACEUTICAL COMPOSITION CONTAINING IBUPROPHEN AND ITS PREPARATION PROCEDURE. | |
MXPA03007857A (en) | Compounds and compositions for delivering active agents. | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
MX2010004556A (en) | Pharmaceutical formulation of clavulanic acid. | |
HK1022265A1 (en) | Biodegradable microparticles for the sustained delivery of therapeutic drugs | |
WO2003028624A3 (en) | Levothyroxine compositions and methods | |
MY141012A (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
NO20023551D0 (en) | Ibuprofen-containing active agent preparation | |
MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
CY1107295T1 (en) | STABILIZATION OF SOLID FORMULON MEDICATIONS FOR THYROID | |
BR0209155A (en) | Pharmaceutical tablet having a high api content |